Lv11
36 积分 2024-12-06 加入
Neuroprotective effects of GLP-2 and a GLP-2/GIP dual receptor agonist in an MPTP-induced mouse model of Parkinson's disease
47分钟前
待确认
Discovery of a High-Potency Balanced GLP-1/GIP Dual Agonist by Molecular Dynamics Evolution
5天前
已完结
A unique hormonal recognition feature of the human glucagon-like peptide-2 receptor
26天前
已完结
Dapiglutide, a dual GLP-1 and GLP-2 receptor agonist, for obesity: a randomised, double-blind, placebo-controlled parallel-group, proof-of-concept trial
30天前
已完结
The Affinity Advantage
1个月前
已完结
Farnesylation-driven KRAS phase separation promotes colon tumor growth
1个月前
已完结
Recent Developments in Therapeutic Peptides for the Glucagon-like Peptide 1 and 2 Receptors
2个月前
已完结
Discovery of a High-Potency Balanced GLP-1/GIP Dual Agonist by Molecular Dynamics Evolution
2个月前
已完结
Creating Glepaglutide, the First Long-Acting GLP-2 Analogue to Enable a Ready-to-Use Injection
2个月前
已完结
皖公网安备34019202002308
